Most U.S. doctors are quietly using this AI tool
Approximately 65% of U.S. doctors use the AI tool OpenEvidence for clinical decisions, medical knowledge updates, and exam preparation. It offers tailored answers but raises concerns about hallucinations, incomplete responses, and erosion of critical thinking. Despite privacy issues, OpenEvidence has rapidly grown, with its valuation soaring from $1 billion to $12 billion.
Most U.S. doctors are quietly using this AI tool
Report an error
The correction channel is not available yet. You can copy the article reference below for later.
Correction instructionsSummary only
Under the source content permission, this page provides an editorial summary, key points, and a link to the original article.